Looking to learn more about Ibogaine, the primary psychoactive extract of T. iboga? During the days of March 14-16th the 2016 Global Ibogaine Conference will bring together experts worldwide to discuss ibogaine therapy, the climate of global drug policy, and the sustainability and traditional uses of Tabernanthe iboga in Tepoztlan, Mexico.
Beginning in the 1980s ibogaine has been used increasingly in the detoxification from opiates and as a treatment for substance use disorders. Early clinical trials were promising, but were later cut short. Their website explains:
Ibogaine’s use has continued to grow, from the early peer-to-peer drug user networks, to today when ibogaine is administered under compassionate access or experimental legal frameworks in some progressive hospitals, medical centers, retreats, and private therapeutic practices around the world. The landscape of ibogaine research and practice has changed dramatically. However, ibogaine’s continued promotion as a ‘cure for addiction’ overemphasizes it’s potential as a stand-alone therapy while contemporary understandings of addictions address a complex biological, psychological and social foundations of addictive behavior. This conference will bring refreshing voices from across the spectrum of traditional practice, medicine, psychology, harm reduction and drug policy in order to advance the use of ibogaine in a comprehensive therapeutic framework.
To find out more about the Global Ibogaine Conference, visit their website here.